Clinical Trial Update: Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

View source ↗

Summary

A long-term safety/efficacy trial update for LipaCreon in patients with pancreatic exocrine insufficiency, completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Diseases
• Exocrine Pancreatic Insufficiency
• Pancreatic Diseases

Drugs mentioned

• LipaCreon

Snippet

Sponsor: Mylan Inc. | Conditions: Exocrine Pancreatic Insufficiency, Pancreatic Diseases | Status: COMPLETED | Results posted: 2022-06-13